Taconic Insights

Biopharmaceutical Trends and R&D

Taconic Biosciences has remained one of the world's leading providers of research models and services for over 60 years through our commitment to anticipating clients’ needs and industry trends. One of the key trends of the past ten years involves our clients’ need to strategically outsource functional areas of their R&D programs. When companies, academic institutions, government agencies and others outsource certain R&D functions they begin to rely on their collaborators, such as Taconic, to keep them apprised of emerging science and technologies in our specific areas of expertise.
In this spirit of collaboration, we present "Taconic Insights", a new section of our website dedicated to educating the industry on key scientific and technological trends impacting biopharmaceutical R&D. Here you will find the latest insights Taconic can provide in the form of articles, white papers, videos, webinars, presentations, and other media.

Genetic Variation in C57BL/6 ES Cells and Knockout Mice

Genetically engineered animal models (GEMs) are powerful tools for biomedical research and drug discovery, but genetic variation in animal models derived from distinct ES cell lines and subsequent breeding can impact both the interpretation and reproducibility of studies which employ them1. While recent advances in gene editing accelerated the migration of models to a pure C57BL/6 background, researchers should remain aware of potentially confounding results from genetic...

Read More

Accelerating Parkinson's Disease Research Through Strategic Partnerships

The Michael J. Fox Foundation (MJFF), established in 2000, is dedicated to finding a cure for Parkinson's disease (PD) by supporting research agendas toward development of improved therapies for Parkinson's disease patients. Unlike many private research funding institutions that rely on external scientific advisors and boards for how to allocate donor-raised research dollars, the MJFF has an in-house team of trained scientists and project managers that oversee...

Read More

The Real Impact of Rodent Diet on Microbiome and Gut Health Research Webinar Q&A

Dr. Michael Pellizzon of Research Diets, Inc., recently presented a webinar on the underappreciated impact of rodent diets on microbiome and gut health research, where simple husbandry decisions can profoundly affect both animal model phenotypes and experimental outcomes. Due to time constraints, many of the questions submitted during the webinar went unanswered. We present a full Q&A here. Impact of Purified Diets Dr. Michael Pellizzon (MP): Yes....

Read More

Review of 3rd Annual Translational Microbiome Conference

This year was the 3rd year of the Translational Microbiome Conference held in Boston, Massachusetts. Boston is a major hub of microbiome research in academia, biotech, and pharma industries. This conference draws attendees from around the world who all want to better understand how the microbiome can be harnessed to improve human health. New this year were workshops held the day before the general sessions began. One...

Read More

Cystic Fibrosis Treatment from Vertex May Restore Lung Function

Cystic Fibrosis (CF) is a genetic disorder that affects the lungs, digestive system, and a host of metabolic functions. In humans, CF is a progressive disease, where chronic dysfunction of muco-ciliary clearance leads to severe congestion, thick mucus build-up, and severe persistent lung infections. In 1960 the median life expectancy for a patient with CF was ten years old. However, with significant advances in research and clinical...

Read More

Selecting Donors for Fecal Microbiota Transplantation

While fecal microbiota transplantation (FMT) is viewed as a relatively inexpensive and safe method for treating recurring Clostridium difficile infection and other maladies in humans, FMT is not without its challenges, particularly with regard to the screening and selection of fecal donors. In a recent Gut Microbes publication, Woodworth et al. discussed current challenges pertaining to FMT for human use1. The authors evaluate current recommendations for selection...

Read More

A First-Person Account of the Microbiome Revolution

Segmented filamentous bacteria (SFB) in the terminal ileum of an 8-week-old Taconic B6 mouse In a new commentary article in Cell Host & Microbe, Ivaylo Ivanov provides a first-person account of the discovery that microbiota composition affects immune system development and response. Ten years after the first studies showing that development of Th17 cells were regulated by the microbiome, Ivanov details how those discoveries were made. As...

Read More

Probiotics and Animal Health

It's common knowledge that the microbiome is a hot area of biomedical research, with pharma and biotech placing big bets on microbiome therapeutics. But did you know that microbiome research and probiotics are also of interest to the animal health and agriculture markets? Farmers routinely treat livestock with low-dose antibiotics to promote growth, but that practice has been widely criticized as leading to the development of antimicrobial...

Read More

Experimental Impacts of Stress and Microbiome

Exposure to stressful situations is difficult to avoid in the life of the laboratory mouse, but study design rarely accounts for the phenotypic effects of stress and the microbiome. Inevitable events and procedures, such as transportation, handling, and restraint, are known to induce stress in mice. Usually the stress response is transient and stabilizes within a period of time. The time until stabilization depends upon many things,...

Read More

Syngeneic Tumor Model Health Standards

The growth in immuno-oncology research, in which the body's own immune system is recruited to fight a tumor, has prompted a shift in preclinical animal models used for oncology research. While traditional cell line xenografts in immunodeficient models are still widely used, they are generally not appropriate for immuno-oncology studies as they lack critical immune cell types required for immunotherapy efficacy. Immuno-oncology researchers have turned to two...

Read More